Cost-effectiveness of sirolimus-eluting stents compared with bare-metal stents
Caroline Barranco
This article has no abstract so we have provided the first paragraph of the full text.
Sirolimus-eluting stents are proven to provide clinical benefits for patients undergoing percutaneous coronary intervention, but are more costly than bare-metal stents. A group from the Netherlands has evaluated whether the lower reintervention rates observed in recipients of sirolimus-eluting stents balance the higher initial cost of treatment.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
